Skip to main content

Natixis Advisors, L.P.

SEC CIK
0001018331
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
1,062,858
Value
$96.4M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Natixis Advisors, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,062,858$96.4M0.1%−675,098−38.8%ReducedHolders
Q1 20261,737,956$178.4M0.2%+153,296+9.7%AddedHolders
Q4 20251,584,660$198.5M0.3%−184,696−10.4%ReducedHolders
Q3 20251,769,356$237.0M0.3%+39,569+2.3%AddedHolders
Q2 20251,729,787$235.3M0.4%+124,984+7.8%AddedHolders
Q1 20251,604,803$212.9M0.4%+12,239+0.8%AddedHolders
Q4 20241,592,564$180.1M0.3%+169,549+11.9%AddedHolders
Q3 20241,423,015$162.2M0.3%+204,478+16.8%AddedHolders
Q2 20241,218,537$126.6M0.3%+242,239+24.8%AddedHolders
Q1 2024976,298$111.0M0.3%+10,368+1.1%AddedHolders
Q4 2023965,930$106.3M0.3%+263,186+37.5%AddedHolders
Q3 2023702,744$68.1M0.2%−421,202−37.5%ReducedHolders
Q2 20231,123,946$122.5M0.4%+217,661+24.0%AddedHolders
Q1 2023906,285$91.8M0.3%−159,612−15.0%ReducedHolders
Q4 20221,065,897$117.0M0.4%+74,766+7.5%AddedHolders
Q3 2022991,131$95.9M0.4%+137,412+16.1%AddedHolders
Q2 2022853,719$92.8M0.4%−65,640−7.1%ReducedHolders
Q1 2022919,359$108.8M0.4%+8,016+0.9%AddedHolders
Q4 2021911,343$128.3M0.5%+53,627+6.3%AddedHolders
Q3 2021857,716$101.3M0.4%+30,193+3.6%AddedHolders
Q2 2021827,523$95.9M0.5%+31,026+3.9%AddedHolders
Q1 2021796,497$95.5M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.